| Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia RF Schlenk, K Döhner, J Krauter, S Fröhling, A Corbacioglu, L Bullinger, ... New England Journal of Medicine 358 (18), 1909-1918, 2008 | 2073 | 2008 |
| Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation P Armand, HT Kim, BR Logan, Z Wang, EP Alyea, ME Kalaycio, ... Blood, The Journal of the American Society of Hematology 123 (23), 3664-3671, 2014 | 841 | 2014 |
| Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation RC Lindsley, W Saber, BG Mar, R Redd, T Wang, MD Haagenson, ... New England Journal of Medicine 376 (6), 536-547, 2017 | 703 | 2017 |
| Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation NS Majhail, SH Farnia, PA Carpenter, RE Champlin, S Crawford, ... Biology of Blood and Marrow Transplantation 21 (11), 1863-1869, 2015 | 502 | 2015 |
| Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis P Teira, M Battiwalla, M Ramanathan, AJ Barrett, KW Ahn, M Chen, ... Blood, The Journal of the American Society of Hematology 127 (20), 2427-2438, 2016 | 493 | 2016 |
| Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ... Biology of Blood and Marrow Transplantation 21 (2), 266-274, 2015 | 418 | 2015 |
| Current use of and trends in hematopoietic cell transplantation in the United States A D'Souza, C Fretham, SJ Lee, M Arora, J Brunner, S Chhabra, S Devine, ... Biology of Blood and Marrow Transplantation 26 (8), e177-e182, 2020 | 414 | 2020 |
| Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel T De Witte, D Bowen, M Robin, L Malcovati, D Niederwieser, ... Blood, The Journal of the American Society of Hematology 129 (13), 1753-1762, 2017 | 362 | 2017 |
| Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia W Saber, S Opie, JD Rizzo, MJ Zhang, MM Horowitz, J Schriber Blood, The Journal of the American Society of Hematology 119 (17), 3908-3916, 2012 | 311 | 2012 |
| Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation J Pidala, SJ Lee, KW Ahn, S Spellman, HL Wang, M Aljurf, M Askar, ... Blood, The Journal of the American Society of Hematology 124 (16), 2596-2606, 2014 | 280 | 2014 |
| Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies W Saber, T Moua, EC Williams, M Verso, G Agnelli, S Couban, A Young, ... Journal of Thrombosis and Haemostasis 9 (2), 312-319, 2011 | 249 | 2011 |
| Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI EA Copelan, BK Hamilton, B Avalos, KW Ahn, BJ Bolwell, X Zhu, M Aljurf, ... Blood, The Journal of the American Society of Hematology 122 (24), 3863-3870, 2013 | 186 | 2013 |
| Indications for hematopoietic cell transplantation and immune effector cell therapy: guidelines from the American Society for Transplantation and Cellular Therapy AS Kanate, NS Majhail, BN Savani, C Bredeson, RE Champlin, ... Biology of Blood and Marrow Transplantation 26 (7), 1247-1256, 2020 | 184 | 2020 |
| Hematopoietic stem-cell transplantation for advanced systemic mastocytosis C Ustun, A Reiter, BL Scott, R Nakamura, G Damaj, S Kreil, R Shanley, ... Journal of Clinical Oncology 32 (29), 3264, 2014 | 181 | 2014 |
| Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation YB Chen, AA Lane, BR Logan, X Zhu, G Akpek, MD Aljurf, AS Artz, ... Biology of Blood and Marrow Transplantation 21 (6), 1046-1053, 2015 | 176 | 2015 |
| Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant … V Gupta, AK Malone, PN Hari, KW Ahn, ZH Hu, RP Gale, KK Ballen, ... Biology of Blood and Marrow Transplantation 20 (1), 89-97, 2014 | 154 | 2014 |
| Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation M Hamadani, PN Hari, Y Zhang, J Carreras, G Akpek, MD Aljurf, E Ayala, ... Biology of Blood and Marrow Transplantation 20 (11), 1729-1736, 2014 | 148 | 2014 |
| Tocilizumab for the treatment of steroid refractory graft-versus-host disease WR Drobyski, M Pasquini, K Kovatovic, J Palmer, JD Rizzo, A Saad, ... Biology of Blood and Marrow Transplantation 17 (12), 1862-1868, 2011 | 140 | 2011 |
| Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and … V Bachanova, DI Marks, MJ Zhang, H Wang, M de Lima, MD Aljurf, ... Leukemia 28 (3), 658-665, 2014 | 139 | 2014 |
| Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma LJ Costa, MJ Zhang, X Zhong, A Dispenzieri, S Lonial, A Krishnan, ... Biology of Blood and Marrow Transplantation 19 (11), 1615-1624, 2013 | 128 | 2013 |
